Germany Graves’ disease Market: Size, Share, Growth, Industry Analysis, Opportunities and Forecast 2019-2025
Germany Graves’ disease market is growing at a CAGR of around 4.3% during the forecast period. Germany is one of the major players in the European region. The growing patient population in the region is one of the major driving forces of such a huge spending in Germany. Moreover, the growing demand for the quality healthcare services in the region is another factor boosting the market. Increasing prevalence of type-1 diabetes is one of the key factors likely to increase the prevalence of Grave’s disease in the country. This is expected to create opportunities for increased demand of advanced treatment options and in turn influences the Germany Graves’ disease market.
To know more information, please request a free report sample https://www.omrglobal.com/request-sample/germany-graves-disease-market
Germany is among the top ten countries across the globe in which the prevalence of type-1 diabetes is on a high. According to the International Diabetes Federation, the number of children and adolescents with type-1 diabetes were 28,600. As the prevalence of such disease increases, it is expected to increase the risk associated with prevalence of Grave’s disease, thereby creating opportunity for the growth of the Germany Graves’ disease market in the near future.
A full report of Germany Graves’ disease Market is available at: https://www.omrglobal.com/industry-reports/germany-graves-disease-market
Further, the healthcare expenditure in Germany has also been increasing significantly in the past years, which is expected to be followed in the future. This is expected to be one of the key reasons which increase the inflow of R&D funds in autoimmune diseases such as Grave’s disease in the future. This is expected to create opportunities for the development of the Germany Graves’ disease market over the forecast period.
Germany Graves’ disease Market – Segmentation
by Diagnosis
- Ultrasound
- Imaging Tests
- Radioactive Iodine Uptake
- Blood Sample
by Treatment
- Anti- Thyroid Medication
- Radioactive Iodine Therapy
- Surgery
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/germany-graves-disease-market
Company Profiles
- Abbott Laboratories Inc.
- Allergan PLC
- Eli Lilly and Co.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Macleods Pharmaceuticals Ltd.
- Merck & Co. Inc.
- Mylan NV
- Novartis International AG
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
European Graves’ Disease Market: Global Size, Share, Industry Trends, Research and Forecast 2019-2025
European Graves’ disease market is growing at a CAGR of around 4.4% during the forecast period. Europe consists of numerous key economies including the UK, Germany, Spain, Italy, and Russia among various others which play a significant role in the development of the Grave’s market in the region. The key reason which is promoting the growth of the market in Europe is the changing lifestyle and higher prevalence of smoking in the countries of European region is expected to promote the prevalence of Grave’s disease, thereby creating opportunity for the growth of the European Graves’ diseases market over the forecast period.
To know more information, please request a free report sample https://www.omrglobal.com/request-sample/european-graves-disease-market
Europe is the well-established region comprises of few of the largest economies of the world. The region has established healthcare industry due to growing funding in the healthcare R&D and awareness programs. This directly impacts the funding and awareness about thyroid related diseases such as Grave’s disease, thyroid cancer and others. Presence of the key market players such as Apitope technology Ltd., GlaxoSmithKline PLC and others is also affecting the growth of the market. Growing prevalence of type-1 diabetes is one of the major factors contributing significantly in the European Grave’s disease market.
A full report of European Graves’ Disease Market is available at: https://www.omrglobal.com/industry-reports/european-graves-disease-market
Further, Apitope International NV is a biotechnology company, based in Belgium, that manufactures and markets commercialized products for autoimmune disease. The company provides product candidate ATX-GD-59 that is a disease-modifying treatment for Grave’s disease. ATX-GD-59 is presently being assessed in a Phase I study in patients and the company plans to initiate a Phase II study in the first quarter of 2019. Thus, the presence of the market players strengthens the domestic presence and also aids in the growth of the European Graves’ disease market.
European Graves’ Disease Market – Segmentation
by Diagnosis
- Ultrasound
- Imaging Tests
- Radioactive Iodine Uptake
- Blood Sample
by Treatment
- Anti- Thyroid Medication
- Radioactive Iodine Therapy
- Surgery
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/european-graves-disease-market
Global Airport Security Systems Market – Segment by Region
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- Abbott Laboratories Inc.
- Allergan PLC
- Eli Lilly and Co.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Macleods Pharmaceuticals Ltd.
- Merck & Co. Inc.
- Mylan NV
- Novartis International AG
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
China Graves’ disease Market: Growth, Size, Share and Forecast 2019-2025
China Graves’ disease market is expected to grow at a CAGR of around 5.8% during the forecast period. Chinese Economy is growing considerably, and it has become a preferred destination for setting business due to cheap labor, improved infrastructure, and a large customer base. China’s market has both medium and long-term potential due to its large market size, aging population, fluctuating disease profile and rapidly improving life. The Chinese economy is becoming an R&D-intensive economy which is the major factor for the growth of the life science industry of China, and in turns affects China Graves’ disease market. Along with this, government support in the country is also affecting the growth of the market. The corporate tax rate in China is 16% as compared with other countries including India at around 35%. China has a large number of pharmaceutical and medical device companies as it is the manufacturing hub for pharmaceutical drugs base supplies.
To know more information, please request a free report sample https://www.omrglobal.com/request-sample/china-graves-disease-market
Further, the prevalence of diabetes in China is increasing at an alarming rate, owing to the increasing geriatric population in the country along with unhealthy dietary habits and lack of physical activity. According to IDF, China has the largest number of people suffering from diabetes. Moreover, there are over 46,900 children and adolescents suffering from type-1 diabetes, owing to the large population of individuals of this age group in the country. Such a high prevalence and incidence rate of diabetes in the country possesses a high risk for the development of Grave’s disease in the patients, thus influencing the China Graves’ disease market.
A full report of China Graves’ disease Market is available at: https://www.omrglobal.com/industry-reports/china-graves-disease-market
Further, the footprints of the key players such as Abbott Laboratories Inc., Allergan PLC, Eli Lilly and Co., GlaxoSmithKline PLC, Merck & Co. Inc., Mylan NV, Novartis International AG including other regional players are also driving the China Graves’ disease market. Besides, there were numerous activities done for the development of an improved method for the establishment of a model of Graves' disease in BALB/c mice, and various other research activities.
China Graves’ disease Market – Segmentation
by Diagnosis
- Ultrasound
- Imaging Tests
- Radioactive Iodine Uptake
- Blood Sample
by Treatment
- Anti- Thyroid Medication
- Radioactive Iodine Therapy
- Surgery
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/china-graves-disease-market
Company Profiles
- Abbott Laboratories Inc.
- Allergan PLC
- Eli Lilly and Co.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Macleods Pharmaceuticals Ltd.
- Merck & Co. Inc.
- Mylan NV
- Novartis International AG
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
Canada Graves’ Disease Market: Growth, Size, Share and Forecast 2019-2025
Canada Graves’ disease market is growing at a CAGR of around 6.3% during the forecast period. Due to increasing awareness of thyroid disease in the country by various government organizations, the Canada Graves’ disease market is expected to grow. For instance, June is celebrated as thyroid awareness month in Canada. The Thyroid Foundation of Canada (TFC), a non-profit organization established in 1980 with the objective of supporting patients suffering from thyroid disease. The foundation has given nearly $1 million for researches on thyroid disease. This funding supports in researches on thyroid disease.
To know more information, please request a free report sample https://www.omrglobal.com/request-sample/canada-graves-disease-market
As Grave’s is the most common autoimmune thyroid disease, this may result in a significant rise in researches for discovering effective medication for patients. Moreover, according to TFC, Grave’s disease is by far the most common cause of hyperthyroidism in Canada. Grave’s disease affects nearly one in every 100 people in Canada, which in turn creates significant scope for the growth of Canada Graves’ disease market.
A full report of Canada Graves’ Disease Market is available at: https://www.omrglobal.com/industry-reports/canada-graves-disease-market
Further, a significant number of smokers in Canada are also a major cause of Grave’s disease in Canada. According to Statistics Canada, in 2017, 16.2% of Canadians aged 12 and over, which is nearly 5 million people smoked either daily or occasionally. Of the 5 million current smokers, 3.6 million smoked cigarettes every day. According to the British Thyroid Foundation, Cigarette smoking is identified to have a key influence on Grave’s disease and on thyroid eye disease (TED).
Smoking can lead to Grave’s disease as it consists of thousands of chemicals and among which some can stimulate the immune system for reacting against the thyroid. Moreover, smokers with Grave’s disease are nearly two times more expected to develop TED. This represents the relation of smoking with Grave’s disease and thereby results in the adoption of anti-thyroid medication for the treatment of the condition, which in turn positively affects the Canada Graves’ disease market growth.
Canada Graves’ Disease Market – Segmentation
by Diagnosis
- Ultrasound
- Imaging Tests
- Radioactive Iodine Uptake
- Blood Sample
by Treatment
- Anti- Thyroid Medication
- Radioactive Iodine Therapy
- Surgery
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/canada-graves-disease-market
Company Profiles
- Abbott Laboratories Inc.
- Allergan PLC
- Eli Lilly and Co.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Macleods Pharmaceuticals Ltd.
- Merck & Co. Inc.
- Mylan NV
- Novartis International AG
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
Global Hemapheresis Market Research and Forecast, 2018-2023
Global hemapheresis market, size, share, market trends, research and analysis report by technology (centrifugation, membrane separation) by application (hematology, neurology, renal disease) forecast 2018-2023
Increasing prevalence of chronic diseases is augmenting the growth of global hemapheresis market.
According to the OMR analysis, the global hemapheresis market is growing at a considerable rate during 2018-2023. The growth of the market is attributed to the increasing prevalence of chronic diseases such as CHDs (Coronary Heart Diseases), CVDs (Cardiovascular Diseases), Cancer and so forth. In addition, growing demand for plasma in pharmaceutical and biotechnology companies further boost the growth of global hemapheresis market. The global hemapheresis market is segmented on the basis of technology, product, application, and geography. The report provides detailed and insightful chapters which includes market overview, key findings, strategic recommendations, market determinants, key company analysis, company profiling, market segmentation, geographical analysis, and analyst insights.
Full report of global hemapheresis market is available at Global Hemapheresis Market
Increasing economic burden due to life-style oriented diseases around the globe contribute the growth of global hemapheresis market. There has been an increase in the number of patients with various blood-related diseases, as well as neurological disorders and metabolic diseases. The blood cells, lymph nodes and bone marrow are affected by various cancers such as leukemia, and myelodysplastic syndromes (MDS). Hemapheresis has been widely adopted technology for reducing number of white cells until other medications can control them. As per the Leukemia & Lymphoma Society (LLS) in 2018, approximately for every 3 minutes, one person in the US is diagnosed with blood cancer. An estimated 1.3 million people in the US are either living with, or are in remission from, leukemia, lymphoma or myeloma. With the rise in such disease, the technology has been widely adopted for the treatment of these diseases.
Global hemapheresis market is analyzed on the basis of the geographical regions- North America, Asia-Pacific, Europe and Rest of the World that are contributing significantly towards the growth of the market. North America is estimated to hold the significant share in the global hemapheresis market due to high prevalence rate of chronic diseases in the region and well-established healthcare infrastructure. In addition, increasing demand for plasma-derived medicines further contributes to the growth of the market in this region. Moreover, Asia-Pacific is estimated to have a considerable growth rate due to the increasing geriatric population, chronic diseases and rapidly increasing healthcare expenditure. In addition, the Asian countries such as China and India have large patient pool and increasing geriatric population that further boost the growth of this region.
The report covers
- Comprehensive research methodology of the global hemapheresis market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global hemapheresis market.
- Insights about market determinants which are stimulating the global hemapheresis market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For related reports please visit Medical Devices Industry
Media Contact:
Company Name: Orion Market Research
Contact Person: Anurag Tiwari
Email: info@omrglobal.com
Phone: +917803040404
Address: 116, Shagun Arcade, Vijay Nagar Square
City: Indore
State: Madhya Pradesh
Country: India
Website: www.omrglobal.com
